NCT00235859View on ClinicalTrials.gov

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 31, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

adalimumab

DRUG

methotrexate

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
collaborator

Eisai Limited

INDUSTRY

lead

Abbott

INDUSTRY